Tdspharm Co., Ltd. (KOSDAQ:464280)

Tdspharm Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	15,203	4,704	1,636	2,937	1,622	2,340
Short-Term Investments	15,000	26,000	13,500	7,000	6,500	5,000
Cash & Short-Term Investments	30,203	30,704	15,136	9,937	8,122	7,340
Cash Growth	-5.23%	102.86%	52.32%	22.34%	10.66%	59.17%
Accounts Receivable	5,683	5,182	6,575	5,596	3,013	3,232
Other Receivables	166.74	480.95	230.7	102.73	1.39	-
Receivables	5,929	5,743	6,806	5,699	3,014	3,232
Inventory	2,784	3,151	2,493	2,163	1,939	1,739
Prepaid Expenses	16.69	16.67	8.53	8.75	10.66	21.44
Other Current Assets	49.53	24.61	36.15	142.14	47.95	20.87
Total Current Assets	38,983	39,640	24,480	17,950	13,134	12,354
Property, Plant & Equipment	8,907	8,881	8,917	9,705	10,207	11,113
Long-Term Investments	31.12	-	-	1,969	3,384	2,827
Other Intangible Assets	140.9	173	51.54	-0	-0	152.29
Long-Term Deferred Tax Assets	175.03	162.43	207.95	493.84	-	42.96
Long-Term Deferred Charges	91.68	115.26	146.69	157.17	151.67	-
Other Long-Term Assets	3,186	188.95	167.01	193.54	90.16	108.14
Total Assets	51,515	49,161	33,970	30,469	26,967	26,598
Accounts Payable	1,637	1,543	2,266	2,220	1,249	1,302
Accrued Expenses	657.37	68.3	73.61	75.04	45.56	36.87
Short-Term Debt	6,360	6,000	6,000	6,000	7,000	7,000
Current Portion of Long-Term Debt	-	775	200	-	-	-
Current Portion of Leases	49.62	79.16	75.74	102.2	49.82	34.33
Current Income Taxes Payable	418.02	1,078	273.57	411.92	408.58	143.76
Other Current Liabilities	1,074	974.03	1,176	1,021	832.78	731.05
Total Current Liabilities	10,196	10,517	10,065	9,830	9,585	9,248
Long-Term Debt	-	-	775	675	-	-
Long-Term Leases	43.77	72.04	94.7	173.89	90.34	24.13
Pension & Post-Retirement Benefits	-	-	35.37	1,421	1,094	986.69
Long-Term Deferred Tax Liabilities	-	-	-	-	23.19	-
Other Long-Term Liabilities	85.12	67.03	55.05	59.91	31.22	0
Total Liabilities	10,325	10,656	11,025	12,160	10,824	10,259
Common Stock	553	553	500	500	500	500
Additional Paid-In Capital	9,970	9,970	-	-	-	-
Retained Earnings	31,979	29,294	25,736	21,260	17,804	15,741
Treasury Stock	-881.35	-881.35	-2,706	-2,706	-2,706	-
Comprehensive Income & Other	-431.07	-431.07	-584.88	-745.34	544.66	97.48
Shareholders' Equity	41,190	38,504	22,945	18,308	16,143	16,339
Total Liabilities & Equity	51,515	49,161	33,970	30,469	26,967	26,598
Total Debt	6,453	6,926	7,145	6,951	7,140	7,058
Net Cash (Debt)	23,750	23,778	7,991	2,986	982.27	281.25
Net Cash Growth	-4.75%	197.58%	167.60%	203.99%	249.25%	-
Net Cash Per Share	4491.65	5135.70	1876.65	700.79	10630.51	2812.57
Filing Date Shares Outstanding	5.29	5.29	4.26	4.26	0.09	0.1
Total Common Shares Outstanding	5.29	5.29	4.26	4.26	0.09	0.1
Working Capital	28,786	29,123	14,414	8,120	3,549	3,106
Book Value Per Share	7786.03	7280.75	5388.68	4296.83	174704.28	163392.49
Tangible Book Value	41,049	38,331	22,893	18,308	16,143	16,187
Tangible Book Value Per Share	7759.40	7248.04	5376.58	4296.83	174704.29	161869.60
Land	1,817	2,020	2,020	2,020	2,020	2,020
Buildings	6,670	7,420	7,531	7,531	7,531	7,531
Machinery	7,933	9,114	8,599	8,457	8,088	7,662
Construction In Progress	806.49	231.19	190.08	127.21	-	260.4

Source: S&P Global Market Intelligence. Standard template. Financial Sources.